We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > cUTI

News List

Iterum hit by failure of anti-infective sulopenem pharmatimes
June 04, 2020
Shares in Dublin, Ireland and Chicago, US-based Iterum Therapeutics have taken a hit on news that the firm's sulopenem did not achieve statistical non-inferiority relative to ertapenem in a trial in complicated urinary tract infection (cUTI).
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections drugs
July 19, 2019
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections.
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections drugs
July 18, 2019
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections.
FDA Approves New Antibacterial Drug pharmaceutical-technology
August 31, 2017
The U.S. Food and Drug Administration approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria.